Half-dose ocrelizumab in selected patients with relapsing–remitting multiple sclerosis

Detalles Bibliográficos
Autores principales: Algahtani, Hussein, Shirah, Bader, Alqahtani, Abdulhadi, Abdelghaffar, Nawal, Makki, Samiah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257484/
https://www.ncbi.nlm.nih.gov/pubmed/37301802
http://dx.doi.org/10.1007/s13760-023-02303-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257484/
https://www.ncbi.nlm.nih.gov/pubmed/37301802
http://dx.doi.org/10.1007/s13760-023-02303-0

Ejemplares similares